-
Product Insights
NewLikelihood of Approval Analysis for End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)
Overview How likely is it that the drugs in End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. End-Stage Kidney Disease (End-Stage Renal Disease...
-
Sector Analysis
NewAutomotive Front End Modules Market Trends, Sector Overview and Forecast to 2028
Automotive Front-End Modules Market Report Overview The automotive front-end modules market size was 91 million units in 2023. The market will grow at a CAGR of more than 1% during 2023-2028. The need to make automotive applications dependable, small, safe, and less expensive is driving the automotive front-end module market. Major automotive front-end module manufacturers are integrating cutting-edge technologies into their products. In 2023, Asia-Pacific accounted for a significant share of the automotive front-end modules market. Automotive Front-End Modules Market...
-
Sector Analysis
NewElectric Vehicles (EV) Market Analysis by Region, Product Type, End-Use Type and Forecast to 2031
Accessing the in-depth insights from the ‘Electric Vehicles’ report can help: Gain a valuable understanding of the current and future state of the market, allowing businesses to make informed decisions about market entry, product development, and investments. Identify competitors' capabilities to stay ahead in the market. Identify segments and get an understanding of various stakeholders across different stages of the entire value chain. Anticipate changes in demand and adjust the business development strategies. Identify potential regions and countries for growth opportunities. How is our ‘Electric...
-
Product Insights
NewEpilepsy Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
GlobalData's clinical trial report, “Epilepsy - Global Clinical Trials Review, 2024" provides an overview of Epilepsy Clinical trials scenario. This report provides top line data relating to the clinical trials on Epilepsy. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
NewDecompensated Cirrhosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
GlobalData's clinical trial report, “Decompensated Cirrhosis - Global Clinical Trials Review, 2024" provides an overview of Decompensated Cirrhosis Clinical trials scenario. This report provides top line data relating to the clinical trials on Decompensated Cirrhosis. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
NewMycosis Fungoides Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Mycosis Fungoides Clinical Trial Report Overview A total of 328 mycosis fungoides clinical trials were conducted as of April 2024. The mycosis fungoides clinical trial report provides a comprehensive understanding of the mycosis fungoides clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor type and the prominent sponsors associated with the trials. Key Regions ·       North America ·       ...
-
Product Insights
NewPulmonary Tuberculosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Pulmonary Tuberculosis Clinical Trial Report Overview A total of 504 pulmonary tuberculosis clinical trials were conducted as of April 2024. The pulmonary tuberculosis clinical trial report provides a comprehensive understanding of the pulmonary tuberculosis clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor type and the prominent sponsors associated with the trials. Key Regions ·      North America ·      ...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Nemolizumab in End-Stage Kidney Disease (End-Stage Renal Disease or ESRD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Nemolizumab in End-Stage Kidney Disease (End-Stage Renal Disease or ESRD) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Nemolizumab in End-Stage Kidney Disease...
-
Product Insights
NewSystemic Sclerosis (Scleroderma) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Systemic Sclerosis (Scleroderma) Clinical Trial Report Overview A total of 683 systemic sclerosis clinical trials were conducted as of April 2024. The systemic sclerosis clinical trial report provides a comprehensive understanding of the systemic sclerosis clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor type and the prominent sponsors associated with the trials. Key Regions ·      North America...